Larvol Delta - Updated-Results-from-SingleAgent-Phase-1-Clinical-Trial-of-Peptide-Drug-Conjugate-AVA6000-to-be-Presented-in-a-Poster-at-the-American-Association-of-Cancer-Research-AACR-Annual-Meeting-on-April-9-2024

pro-doxorubicin (AVA6000) - Avacta

https://www.globenewswire.com/news-release/2024/03/05/2840928/0/en/Updated-Results-from-Single-Agent-Phase-1-Clinical-Trial-of-Peptide-Drug-Conjugate-AVA6000-to-be-Presented-in-a-Poster-at-the-American-Association-of-Cancer-Research-AACR-Annual-Me.html

Mar 5, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next